BRCA Rules Leave Patients Behind
November 1st 2019Updated guidelines from the United States Preventive Services Task Force on BRCA1/2 genetic testing recommend risk assessment, counseling, and genetic test-ing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk for developing BRCA1/2 mutation–driven disease
Hepatic Infusion Can Convert CRC Liver Metastases to Operable State
November 1st 2019Overall, compelling response rates and rates of conversion to resection for patients with initially unresectable colorectal liver metastases treated with hepatic arterial infusion suggest consideration of earlier initiation of the technique in chemotherapy-naïve patients as well as its adoption in patients who have failed first-line systemic chemotherapy before proceeding to second- or third-line regimens.
IDO Inhibitor Development Shows Fresh Signs of Life Across Tumor Types
October 31st 2019In the ongoing search for novel immunotherapies that might rival or surpass the efficacy of immune checkpoint inhibitors, drugs targeting IDO1—a key enzyme in tryptophan metabolism—have been a major focus in recent years.
Radiation Oncology Model Will Not Satisfy Need for Payment Reform
October 31st 2019In July 2019, Centers for Medicare & Medicaid proposed the Radiation Oncology Model, an important step forward in allowing the nation’s 4500 radiation oncologists to join in the transition to value-based healthcare.
SITC Introduces Guidelines for Anti–PD-1 Therapy in HNSCC
October 31st 2019Based on strong findings for efficacy and safety, as well as FDA approvals, the Society for Immunotherapy of Cancer has issued the first guidelines for the use of immunotherapy agents in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Early Adjuvant Chemotherapy Dose Reductions Correlate With Poorer Survival in Breast Cancer
October 31st 2019Early dose reductions in a common adjuvant chemotherapy regimen were associated with inferior survival outcomes in a retrospective study of women with intermediate- to high-risk breast cancer.
Can New Oncology Payment Programs Help Stabilize Medicare?
October 30th 2019Studies have raised doubts about the value Medicare and other payers are getting for the care they pay for, including in oncology. This has intensified the demand for new value-based care models such as the Merit-based Incentive Payment System and the Oncology Care Model.